Nplate (romiplostim) - Important Safety Information from Amgen as approved by the Irish Medicines Board
26 January 2011
Important safety information communication from Amgen on revised dose adjustment in ITP patients and warnings for use in ITP patients with hepatic impairment.
Important Safety Information - Nplate (romiplostim)